Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 224 results found. Search for [ Covishield SII ]

Results 1 to 21 of 224
BusinessToday.In
May 14, 2021
The imported doses of the vaccine are presently priced at an MRP of Rs 948 + 5% GST per dose, with the possibility of a lower price point when local supply begins, says RDIF's Indian partner Dr Reddy's Lab


BusinessToday.In
May 14, 2021
Besides asking the Adar Poonawalla-backed pharma behemoth to come to its rescue, the Delhi government's letter mentioned that vaccination centres will have to be shut down due to the non-availability of vaccines


Manoj Sharma | Mudit Kapoor
May 13, 2021
At Rs 300, the expected earnings from, let's say, 500 million doses of Covishield stand at about Rs 15,000 crore, which is near three times the total revenue of Serum Institute in FY20


BusinessToday.In
May 13, 2021
Sputnik V is the third COVID-19 vaccine after SII's Covishield and Bharat Biotech's Covaxin that has received emergency use authorisation from Indian drug regulators


BusinessToday.In
May 13, 2021
Bharat Biotech has been producing Covaxin at its Biosafety Level-3 (BSL-3) facilities in Hyderabad and Bengaluru, where production capacity had been enhanced in a step-wise manner


BusinessToday.In
May 13, 2021
Hyderabad-based Bharat Biotech had proposed to carry out a Phase-II/III clinical trial of Covaxin in the age group of 2 to 18 years. The trial will be conducted in 525 healthy volunteers


BusinessToday.In
May 13, 2021
While Pune-based Serum Institute said it can ramp up the production to 10 crore, the Hyderabad-based Bharat Biotech said they can raise the production to 7.8 crore doses till August


BusinessToday.In
May 13, 2021
Talking to the media following a state cabinet meeting, Maharashtra Health Minister Rajesh Tope said the vaccination for the 18-44 years age group will start after Covishield vaccine doses are received


BusinessToday.In
New Delhi, May 12, 2021
Biocon Executive Chairman Kiran Mazumdar-Shaw has expressed concern over the shortage of COVID-19 vaccines and sought better transparency from the government regarding their availability so that citizens could patiently wait for their turn. \"Can we please know where the 70 million doses are being deployed every month? We need better transparency to avoid suspense. If a timetable of supplies is made public people can patiently wait their turn\", said Shaw in a tweet on Tuesday while tagging the Health Ministry. Earlier this month, the Health Ministry had noted that a 100 per cent advance of Rs 1,732.50 crore was released to the Serum Institute of India (SII) on April 28 for 11 crore doses of Covishield vaccine. The ministry had also stated that against the last order of 10 crore doses for supplies of Covishield vaccine, 8.744 crore doses had been delivered till May 3. Watch the video for more.Also Read: Kiran Mazumdar Shaw expresses concern over COVID-19 vaccine shortage


PTI
May 12, 2021
The aid to India is part of the $1 million which the British-Swedish multinational has earmarked for relief initiatives across communities which have been hit hard by the coronavirus pandemic


BusinessToday.In
May 12, 2021
As of May 11, cumulative number of COVID-19 vaccine doses administered in the country stands at 17,51,71,482. Over 4.74 lakh beneficiaries of the age group 18-44 years received their first dose of COVID vaccine on May 11


Joe C Mathew
May 11, 2021
In an affidavit submitted to the Supreme Court on May 9, the government said the difference in the  prices fixed for Central government, state governments and private market are because of the volumes sought by them


PTI
May 11, 2021
India has announced expansion of its COVID-19 vaccination drive by allowing its large population aged over 18 to get inoculated from May 1


BusinessToday.In
May 6, 2021
RBI Governor Shaktikanta Das announced had a Rs 50,000 lending programme to ramp up COVID-19-related healthcare infrastructure amid massive second wave ravaging India


PTI
May 6, 2021
Providing raw materials for the production of anti-coronavirus vaccines was a major component of the Biden administration's announcement on medical aid to India


PTI
May 4, 2021
COVAX urgently needs 20 million doses during the second quarter of 2021 to cover interruptions in supply triggered by increased demands for vaccines in India where COVAX's main supplier of the AstraZeneca product is based, according to WHO


BusinessToday.In
May 3, 2021
Poonawalla said SII has got 100 per cent advance of Rs 1,732.50 crore by GoI for the next tranche of 11 crore doses in the next few months.


BusinessToday.In
May 3, 2021
Ministry says as of May 2, Centre has provided more 16.54 crore vaccine doses to states/UTs for free. Over 78 lakh doses are still available with states/UTs to be administered and over 56 lakh doses will be received in next three days


BusinessToday.In
May 3, 2021
Coronavirus in India: \"Everybody really felt that India had started to turn the tide on the pandemic,\" said Poonawalla


BusinessToday.In
May 2, 2021
Earlier, Poonawalla had dropped a bombshell by saying in an interview he had extended his stay in London because of the threatening phone calls he had been receiving.


PAGES 1 OF 12  12345